Komori
Tokushu Tokai Paper (3708) · InitiativeReframed

Strengthening the R&D Organization

First written in FY2016. 22 of 32 entries say "Restated". Latest entry: FY2026.

32entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019-Q2 – FY2020-Q3RestatedFY2021-Q3 – FY2022-Q32016: 320162017: 420172018: 320182019: 320192020: 220202021: 320212022: 420222023: 420232024: 320242025: 120252026: 22026
Same theme, other companies
Two-Tier R&D Structure for Basic Research and Business-Unit DevelopmentA theme 5 companies write about · 0 as a headwind · 5 as a tailwind

Tokushu Tokai Paper moved to the "Worse" side of this theme in 2025.

1 other company's latest entry also says "Reframed".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026ReframedAnnual report

    「R&D is being led by the Development Office and the Central Research Institute.」

    The core R&D organizations were reported as the Development Office and the Central Research Institute, instead of the Packaging Division and the Central Research Institute reported previously. R&D expenses were ¥551 million.
  2. 2026-05-20ReframedInvestor presentation

    「A development department specializing in specialty paper was newly established.」

    The research and development structure was reorganized to establish a specialized department to accelerate the development and expansion of specialty paper.
  3. FY2025ReframedAnnual report

    「R&D is being led by the Packaging Division and the Central Research Institute. Total R&D expenses for the current consolidated fiscal year were ¥574 million.」

    The core R&D organizations were reorganized from those previously reported to the Packaging Division and the Central Research Institute. R&D expenses of ¥574 million were disclosed.
  4. FY2025-H1RestatedAnnual report

    「Group-wide R&D expenditure for the current interim consolidated period was ¥274 million. There were no material changes in the status of the Group’s R&D activities during the current interim consolidated period.」

    While reporting no material changes in R&D activities, the company disclosed R&D expenses of ¥274 million for the current interim consolidated period.
  5. FY2024ReframedAnnual report

    「R&D is being led by the Fibric Business Division and the Development Promotion Division. Total R&D expenses for the current consolidated fiscal year were ¥536 million.」

    The Fibric Business Division and the Development Promotion Division were identified as the core R&D organizations, and R&D expenses of ¥536 million were disclosed.
  6. FY2024-Q3RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative third quarter was ¥418 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter.」

    R&D expenses of ¥418 million were recorded, with no material changes reported in the status of R&D activities.
  7. FY2024-Q2RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative second quarter was ¥304 million. There were no material changes in the status of the Group’s R&D activities during the cumulative second quarter.」

    R&D expenses of ¥304 million were recorded, with no material changes reported in the status of R&D activities.
  8. FY2024-Q1RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative first quarter was ¥141 million. There were no material changes in the status of the Group’s R&D activities during the cumulative first quarter.」

    While reporting no material changes in R&D activities, the company disclosed R&D expenses of ¥141 million for the cumulative first quarter.
  9. FY2023AdvancedAnnual report

    「The company also began considering the introduction of MI to improve productivity in the development divisions and is working to establish a structure for more efficient development.」

    The company began considering the introduction of MI into its R&D structure to improve productivity in the development divisions.
  10. FY2023-Q3RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative third quarter was ¥472 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter.」

    While reporting no material changes in R&D activities, the company disclosed R&D expenses of ¥472 million for the cumulative third quarter.
  11. FY2023-Q2RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative second quarter was ¥376 million. There were no material changes in the status of the Group’s R&D activities during the cumulative second quarter.」

    R&D expenses of ¥376 million were recorded, with no material changes reported in the status of R&D activities.
  12. FY2023-Q1RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative first quarter was ¥195 million. There were no material changes in the status of the Group’s R&D activities during the cumulative first quarter.」

    R&D expenses of ¥195 million were recorded, with no material changes reported in the status of R&D activities.
  13. FY2022AdvancedAnnual report

    「R&D is being led by the Fibric Business Division, the Packaging Division, and the R&D Division. Total R&D expenses for the current consolidated fiscal year were ¥935 million, including ¥253 million in strategic R&D expenses not included in the reportable segments.」

    The R&D organization was streamlined into 3 divisions, and R&D expenses of ¥935 million were disclosed for the current consolidated fiscal year, including ¥253 million in strategic R&D expenses.
  14. FY2022-Q3RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative third quarter was ¥706 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter.」

    The Company recorded ¥706 million in research and development expenses and stated that there were no material changes in the status of its research and development activities.
  15. FY2022-Q2RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative second quarter was ¥470 million. There were no material changes in the status of the Group’s R&D activities during the cumulative second quarter.」

    R&D expenses of ¥470 million were recorded, with no material changes reported in the status of R&D activities.
  16. FY2022-Q1RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative first quarter was ¥225 million. There were no material changes in the status of the Group’s R&D activities during the cumulative first quarter.」

    R&D expenses of ¥225 million were recorded, with no material changes reported in the status of R&D activities.
  17. FY2021-Q3RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative third quarter was ¥706 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter.」

    The Company recorded ¥706 million in research and development expenses and stated that there were no material changes in the status of its research and development activities.
  18. FY2021-Q1ReframedAnnual report

    「Following the organizational changes in April 2020, product development is being carried out by the R&D Division and the newly established Packaging Planning Division.」

    The product development structure was reorganized so that development is conducted by the R&D Division and the newly established Packaging Planning Division.
  19. FY2020-Q3RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative third quarter was ¥771 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter.」

    R&D expenses of ¥771 million were recorded, with no material changes reported in the status of R&D activities.
  20. FY2020-Q2RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative second quarter was ¥527 million. There were no material changes in the status of the Group’s R&D activities during the cumulative second quarter.」

    R&D expenses of ¥527 million were recorded, with no material changes reported in the status of R&D activities.
  21. FY2020-Q1RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative first quarter was ¥266 million. There were no material changes in the status of the Group’s R&D activities during the cumulative first quarter.」

    R&D expenses of ¥266 million were recorded, with no material changes reported in the status of R&D activities.
  22. FY2019-Q3RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative third quarter was ¥658 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter.」

    R&D expenses of ¥658 million were recorded, with no material changes reported in the status of R&D activities.
  23. FY2019-Q2RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative second quarter was ¥431 million. There were no material changes in the status of the Group’s R&D activities during the cumulative second quarter.」

    R&D expenses of ¥431 million were recorded, with no material changes reported in the status of R&D activities.
  24. FY2018AdvancedAnnual report

    「The R&D organization was reorganized in July 2017, and a New Business Promotion Office was established. The New Business Promotion Office oversees the Fibric Business Division, the R&D Division (formerly the R&D Center), and the Overseas Business Division, creating a structure in which overseas expansion, new product development, and the exploration and development of new businesses can be coordinated and pursued efficiently within a single organization. The Group had 52 R&D staff in total, equivalent to approximately 4% of total employees.」

    A New Business Promotion Office was established, and the organization was changed to integrate R&D, overseas expansion, new product development, and new business exploration. R&D staff increased from 47 to 52, while their proportion of total employees rose from approximately 3% to approximately 4%.
  25. FY2018-Q3RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative third quarter was ¥650 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter.」

    R&D expenses of ¥650 million were recorded, with no material changes reported in the status of R&D activities.
  26. FY2018-Q2RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative second quarter was ¥422 million. There were no material changes in the status of the Group’s R&D activities during the cumulative second quarter.」

    R&D expenses of ¥422 million were recorded, with no material changes reported in R&D activities.
  27. FY2018-Q1RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative first quarter was ¥203 million. There were no material changes in the status of the Group’s R&D activities during the cumulative first quarter.」

    R&D expenses of ¥203 million were recorded, with no material changes reported in R&D activities.
  28. FY2017AdvancedAnnual report

    「Research and development is currently being pursued by 4 divisions: the company's Fibric Business Division, Research and Development Center, Overseas Development Department of the Overseas Business Division, and Technical Section of 新東海製紙. The Group has 47 R&D staff members, equivalent to approximately 3% of total employees.」

    The R&D organization was streamlined into 4 divisions, and R&D staff increased from 44 to 47. R&D expenses amounted to ¥813 million.
  29. FY2017-Q3RestatedAnnual report

    「The Group's research and development expenditure during the third cumulative quarter of the current consolidated fiscal year was ¥603 million. There were no material changes in the status of the Group's research and development activities during the third cumulative quarter of the current consolidated fiscal year.」

    The company disclosed R&D expenses of ¥603 million and stated that there had been no material changes in its research and development activities.
  30. FY2017-Q2RestatedAnnual report

    「The Group's research and development expenditure during the second cumulative quarter of the current consolidated fiscal year was ¥411 million. There were no material changes in the status of the Group's research and development activities during the second cumulative quarter of the current consolidated fiscal year.」

    The company disclosed R&D expenses of ¥411 million and stated that there had been no material changes in its research and development activities.
  31. FY2017-Q1RestatedAnnual report

    「The Group's research and development expenditure during the first cumulative quarter of the current consolidated fiscal year was ¥184 million. There were no material changes in the status of the Group's research and development activities during the first cumulative quarter of the current consolidated fiscal year.」

    The company disclosed R&D expenses of ¥184 million for the cumulative quarter under review while stating that there had been no material changes in its research and development activities.
  32. FY2016First statedAnnual report

    「Research and development is currently being pursued by the company's Fibric Business Division and Research and Development Division of the Integrated Development Center. The Group has 44 R&D staff members, equivalent to approximately 3% of total employees.」

    The company conducts R&D through 2 organizations and discloses 44 staff members, equivalent to approximately 3% of total employees.
Moved together

"Policy of Using Operating Profit and ROE as Key Management Indicators" moved the same way as this thread, in the same document, in 5 of its 32 moves.

533333★123456
  1. ★This thread
  2. 1Policy of Using Operating Profit and ROE as Key Management Indicators5×
  3. 2Fluctuations in Product Market Conditions3×
  4. 3Interest-Bearing Debt and Interest Rate Fluctuations3×
  5. 4Reduction in Purchased Electricity and CO2 Emissions through a New Biomass Boiler3×
  6. 5Strengthening Oversight by Outside Directors and Outside Audit & Supervisory Board Members3×
  7. 6Progress in Developing New Products Such as Airas3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Tokushu Tokai Paper yet. It last moved in the Investor presentation of 2026-05-20: "Reframed".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.